Status:
UNKNOWN
Effect of Treatment With Stress-Doses Glucocorticoid in Patients With Acute Respiratory Distress Syndrome (ARDS)
Lead Sponsor:
Southeast University, China
Collaborating Sponsors:
Nanjing Medical University
Conditions:
Acute Respiratory Distress Syndrome
Adrenal Insufficiency
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to see if stress doses of hydrocortisone improve early outcome in patients who are in early stage of ARDS and with relative adrenal insufficiency.
Eligibility Criteria
Inclusion
- within the first 3 days of onset of clinically definite ARDS confirmed by AECC criteria in 1994
- 18 to 85 year old
Exclusion
- pregnancy or lactation
- tumor or other immunologic disease
- immunosuppressive drug used
- bone marrow or lung transplantation
- primary or secondary disease of adrenal gland
- hormone used within 3 months
- refusing conventional therapy
- be in other clinical tests within 30 days
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00773058
Start Date
December 1 2008
Last Update
February 18 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.